Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance.

Diabetes Care · 2024 · PMC10909685 · PMID 38151465

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

near statistical significanceno p-value reported

Compared with placebo, the effect of finerenone on the CV composite outcomes across the range of baseline eGDR values reached near statistical significance.

also in 70 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.